The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Moving beyond Karnofsky and ECOG Performance Status Assessments with New Technologies
Open accessAbstract
Progress in cancer research is coupled with increased treatment complexity reliant upon accurate patient selection. Oncologists rely upon measurement instruments of functional performance such as the Karnofsky or Eastern Cooperative Oncology Group Performance Status scales that were developed over fifty years ago to determine a patient’s suitability for systemic treatment. These standard assessment tools have been shown to correlate with response to chemotherapy, chemotherapy tolerability, survival, and quality of life of cancer patients. However, these scales are subjective, subject to bias and high interobserver variability. Despite these limitations important clinical decisions are based on PS including eligibility for clinical trials, the “optimal” therapeutic approach in routine practice, and the allocation of healthcare resources. This paper reviews the past, present, and potential future of functional performance status assessment in an oncology setting. The potential ability of electronic activity monitoring systems to provide an objective, accurate measurement of patient functional performance is explored. Electronic activity monitoring devices have the potential to offer positive health-related opportunities to patients; however their introduction to the healthcare setting is not without difficulty. The potential role of this technology in healthcare and the challenges that these new innovations pose to the healthcare industry are also examined.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Timed “Up & Go”: A Test of Basic Functional Mobility for Frail Elderly Persons
Podsiadlo, D., & Richardson, S. (1991) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1991.tb01616.x · Cited by 14,418 · cited 3×
“TUG [21] Assessment of mobility and functional balance; functional mobility is quantified by the time it takes a patient to get up from a seated position, walk 3 meters, turn around, and return to a seated position Objective Time to completion: seconds Easy to perform Minimal equipment Required Focused on one domain,…”
MethodGuralnik, J. M., Simonsick, E. M., Ferrucci, L., Glynn, R. J., Berkman, L. F., Blazer, D. G., Scherr, P. A., & Wallace, R. B. (1994) · Journal of Gerontology · doi:10.1093/geronj/49.2.m85 · Cited by 9,792
FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
Conroy, T., Desseigne, F., Ychou, M., Bouché, O., Guimbaud, R., Bécouarn, Y., Adenis, A., Raoul, J.-L., Gourgou-Bourgade, S., de la Fouchardière, C., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1011923 · Cited by 7,810
Predicting chemotherapy toxicity in older adults with cancer: a prospective multicenter study
Hurria, A., Togawa, K., Mohile, S. G., Owusu, C., Klepin, H. D., Gross, C. P., Lichtman, S. M., Gajra, A., Bhatia, S., Katheria, V., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2011.34.7625 · Cited by 1,841 · cited 1×
“The existing oncology PS assessment tools previously described were validated in younger patients and do not adequately address the heterogeneity in the aging process [44].”
MethodUse of comprehensive geriatric assessment in older cancer patients:
Extermann, M., Aapro, M., Bernabei, R., Cohen, H. J., Droz, J.-P., Lichtman, S., Mor, V., Monfardini, S., Repetto, L., Sørbye, L., et al. (2005) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2005.06.003 · Cited by 1,098
The Technology of Accelerometry-Based Activity Monitors: Current and Future
CHEN, K. Y., & BASSETT, D. R. (2005) · Medicine & Science in Sports & Exercise · doi:10.1249/01.mss.0000185571.49104.82 · Cited by 996
Accuracy of Smartphone Applications and Wearable Devices for Tracking Physical Activity Data
Case, M. A., Burwick, H. A., Volpp, K. G., & Patel, M. S. (2015) · JAMA · doi:10.1001/jama.2014.17841 · Cited by 694
Randomized Trial of a Fitbit-Based Physical Activity Intervention for Women
Cadmus-Bertram, L. A., Marcus, B. H., Patterson, R. E., Parker, B. A., & Morey, B. L. (2015) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2015.01.020 · Cited by 469 · cited 1×
“device [65].”
Ferguson, T., Rowlands, A. V., Olds, T., & Maher, C. (2015) · International Journal of Behavioral Nutrition and Physical Activity · doi:10.1186/s12966-015-0201-9 · Cited by 468 · cited 1×
“[31] Healthy volunteers 21 Fitbit One, Fitbit Zip, Jawbone Up, Misfit Shine,”
BackgroundValidity of Consumer-Based Physical Activity Monitors
LEE, J.-M., KIM, Y., & WELK, G. J. (2014) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0000000000000287 · Cited by 401 · cited 1×
“, Bluetooth), and (iii) the increased sophistication of personalized social media applications [62].”
Background
Cited by
Azam, F., Latif, M. F., Farooq, A., Tirmazy, S. H., AlShahrani, S., Bashir, S., & Bukhari, N. (2019) · Case Reports in Oncology · doi:10.1159/000503095 · Cited by 374
Cancer cachexia and its pathophysiology: links with sarcopenia, anorexia and asthenia
Peixoto da Silva, S., Santos, J. M. O., Costa e Silva, M. P., Gil da Costa, R. M., & Medeiros, R. (2020) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1002/jcsm.12528 · Cited by 371
Metadata
- Authors
- Kelly, C. M., & Shahrokni, A.
- Venue
- Journal of Oncology
- Publisher
- Hindawi Limited
- Published
- 2016
- Volume
- 2016
- Pages
- 1-13
- ISSN
- 1687-8450 (ISSN-L)
- 1687-8469
- OpenAlex
- W2297171155
- Cited by
- 225
- References
- 15
- FWCI
- 9.92
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Moving beyond Karnofsky and ECOG Performance Status Assessments with New Technologies. https://app.cochat.ai/papers/10.1155/2016/6186543
- The paper
- Kelly, C. M., & Shahrokni, A. (2016). Moving beyond Karnofsky and ECOG Performance Status Assessments with New Technologies. Journal of Oncology. https://doi.org/10.1155/2016/6186543
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.